Evolv Technologies is growing quickly, with revenue up 34% and ARR rising to $132.7 million, but the stock still depends on cleaner execution and a path to durable profitability. The report rates EVLV a Hold with a fair value of $5.50.
Evolv Technologies Holdings Inc. (EVLV) has a credible growth engine, but the stock still requires execution. Q2 2026 revenue rose 34% year over year to $43.8 million, annual recurring revenue reached $132.7 million, and adjusted EBITDA margin expanded to 10.1% from 6.5% a year earlier. Management also raised 2026 revenue guidance to $180 million to $185 million and expects adjusted EBITDA of $15 million to $16 million.
The bullish case rests on a subscription-driven security platform with roughly 9,200 deployed units, more than 700,000 serviceable doorways, 70 new customers added in Q2, and eXpedite adoption that has expanded to more than 100 customers. Evolv also reported that 80% of Q2 unit bookings came from existing customers, a useful sign that the installed base can support account expansion rather than merely one-time equipment sales.
The risk is that growth has not yet translated into consistent GAAP profitability. EVLV reported a Q2 net loss of $9.3 million, an operating margin of -21.4%, and an expected 2026 EPS loss of roughly $0.08. The March 2026 10-K also identified material weaknesses related to revenue recognition. With the stock recently quoted around $4.50, the report assigns a Hold recommendation and a fair value estimate of $5.50. That view gives credit for growth while applying a discount for execution, accounting, and profitability risk.
Founded in 2013 and headquartered in Waltham, Massachusetts, Evolv develops AI-powered weapons detection products for schools, hospitals, sports venues, entertainment sites, workplaces, government facilities, and other high-traffic locations. The company has 286 employees and trades on Nasdaq under EVLV.
The core platform combines proprietary hardware, sensors, AI models, software, data, and services. Evolv Express screens people as they move through an entrance, while Evolv eXpedite screens bags in high-clutter environments. Evolv Insights adds analytics covering visitor flow, arrival curves, system performance, and alarm statistics.
The company has moved away from its former distributor and license structure. Its current model emphasizes pure subscriptions and purchase-subscription contracts, generally lasting four years. That change creates a more visible revenue base, although the purchase-subscription structure recognizes hardware costs upfront and can pressure reported gross margin during deployment periods.
Evolv reports three principal revenue categories: Product, Service, and Subscription and Circulation. The 2025 segment mix assigns 67.2% of revenue to Subscription and Circulation, 24.9% to Service, and 7.9% to Product. That mix supports the view that recurring and service-related revenue are more important than standalone hardware sales.
Subscription and Circulation is the strategic center of the model. ARR was $132.7 million at June 30, 2026, up 20% year over year, while remaining performance obligations reached $312.6 million, up 4.5% sequentially. Management said RPO was more than 1.7 times its 2026 revenue outlook, providing contracted revenue visibility across future periods.
Service revenue supports installation, maintenance, software, and operating workflows around the equipment. Product revenue remains important because the company still deploys physical screening systems, but the purchase-subscription model turns the hardware into an entry point for longer-term software and service revenue. The mix is therefore becoming more like a recurring platform business, although reported results still carry hardware economics.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Evolv Express is the flagship walk-through screening system. Its value proposition is high-throughput detection without the stop-and-search friction associated with older screening methods. Management said the company now screens nearly 5 million people each day and has deployed about 9,200 units.
Gen2 Express upgrades are becoming an important part of the installed-base strategy. Customers are signing new four-year contracts to replace Gen1 deployments, which can increase contract duration and create future revenue. The trade-off is a temporary margin burden from freight, refurbishment, and depreciation on returned Gen1 units.
Evolv eXpedite broadens the product set from people screening to autonomous bag screening. The company reported more than 100 eXpedite customers, representing approximately 8% of its customer base versus 2% a year earlier. Customers have screened more than 20 million bags, with daily volume around 90,000 bags.
The cross-sell data is especially relevant. About 70% of new customers purchasing eXpedite also purchased Express, and Evolv has cross-sold eXpedite to more than 40 existing Express customers. That combination supports a platform strategy in which each account can generate more revenue without requiring a completely new sales relationship.
Evolv's strongest advantage is the combination of physical hardware and software intelligence. A software-only entrant cannot provide the same sensing equipment, while a commodity hardware vendor lacks the same opportunity to build recurring analytics, updates, and services around the installed base.
The data feedback loop is another potential advantage. More than 5 million people pass through Evolv systems each day, while eXpedite has processed more than 20 million bags. That operating data can support model refinement, false-alarm reduction, workflow improvements, and future software features.
The advantage remains conditional on product performance and customer trust. Security buyers care about detection accuracy, visitor throughput, uptime, and operational simplicity. A strong installed base helps, but price competition from conventional metal detectors and larger security providers limits how much premium Evolv can charge.
Evolv onboarded Plexus as a global contract manufacturing partner and began shipping products through its facilities in Q2 2026. Management expects the relationship to expand production capacity, improve geographic reach, strengthen resilience, and reduce bill-of-material costs through purchasing scale.
The company is still managing semiconductor constraints and component cost pressure. Management identified supply-chain costs as roughly a half-point gross-margin headwind in the 2026 outlook. It also expects to invest an additional $2 million to $4 million in inventory safety stock when the timing is attractive.
Operational leverage is beginning to show. Q2 adjusted operating expenses rose 16% year over year to $25.0 million, below the 34% revenue growth rate, while adjusted EBITDA increased to $4.4 million from $2.1 million. The manufacturing transition and higher pricing on Express and eXpedite give management two routes to improve margins, although the near-term mix of purchase subscriptions keeps pressure on reported gross margin.
Evolv is targeting a large but lightly penetrated market. Management estimates more than 700,000 serviceable doorways across its current markets, with about 9,200 units deployed and penetration below 5%. The company has also estimated more than $20 billion in annual potential weapon-screening system sales.
The market is shifting toward screening systems that improve security without creating long entry lines. That matters in schools, hospitals, arenas, museums, workplaces, and transportation hubs, where visitor flow is part of the operating model. The FIFA World Cup deployment, which screened more than 3.5 million fans across venues, festivals, and transportation locations, gave Evolv a visible proof point for high-volume use.
Evolv's 2026 guidance calls for revenue growth of 23% to 27%, deployed-unit growth of about 30%, and ending ARR of $148 million to $150 million. Those figures are materially stronger than the underlying physical security equipment market's typical mid-single-digit growth rates, so the investment case depends on share gains and subscription expansion rather than market growth alone.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Evolv serves organizations where security, throughput, and visitor experience must work together. Its customer base includes approximately 1,800 schools, about 800 hospitals, more than 30 Fortune 500 companies, professional sports organizations, entertainment venues, government offices, and industrial workplaces.
Education was a major Q2 contributor. Evolv added 23 education customers across 13 states, including K-12 schools, higher education institutions, and state education agencies. The company supports 24 of the 100 largest U.S. school districts, and management cited federal grants and state-level school-safety initiatives as demand supports.
Healthcare customers face a different operating challenge. Hospitals need stronger screening while preserving open access for patients, staff, and visitors. Evolv added eight healthcare customers in Q2, including Alberta Health Services, and said workplace violence remains a major reason healthcare providers are prioritizing screening investments.
The installed base is becoming the most attractive customer group. About 80% of Q2 unit bookings came from existing customers, net revenue retention stayed above 100%, and eXpedite cross-sells are expanding. These metrics show that account expansion is already contributing to growth rather than remaining a purely theoretical opportunity.
Evolv competes with Xtract One Technologies, Thruvision Group, Leidos, and Rohde & Schwarz in next-generation screening. It also competes with established walk-through metal detectors, handheld wands, millimeter-wave systems, terahertz imaging, and manual screening processes.
Evolv's differentiation is the combination of touchless screening, high throughput, AI classification, cloud connectivity, and recurring services. Xtract One presents a direct technology comparison, while Leidos and Rohde & Schwarz bring larger-scale engineering, procurement, and defense relationships. Traditional metal detectors remain a powerful alternative because buyers understand them and often acquire them at lower upfront cost.
The competitive test is therefore economic as much as technical. Evolv must show that lower friction, better analytics, and reduced staffing needs justify a premium over conventional equipment. Its 70 new Q2 customers, more than 100 eXpedite customers, and growing Gen2 upgrade activity support product-market traction, but the company's negative operating margin shows that scale has not fully translated into durable earnings.
Public safety spending is the main macro support for EVLV. School-safety funding, healthcare workplace-violence concerns, and security investment at major venues each create budget pathways for adoption. These needs are tied to specific operating and policy pressures rather than a single economic cycle.
The main macro risks are procurement delays, tight institutional budgets, component inflation, tariffs, and semiconductor constraints. Evolv cited modestly higher component and supply-chain costs in its 2026 outlook. International expansion adds opportunity across Canada, Mexico, and other markets, but it also introduces currency, regulatory, logistics, and public-procurement complexity.
Evolv's beta of 1.8 also matters for a moderate-risk investor. Even strong operating results can coexist with sharp stock-price swings when a small-cap company carries a high-growth valuation and remains loss-making. The 52-week trading range of $4.02 to $7.48 illustrates that sensitivity.
Evolv’s balance sheet is not the main issue in this report; the bigger concern is whether rapid growth can be sustained without adding more execution risk.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q2 revenue jumped 34% to $43.8 million and adjusted EBITDA margin improved to 10.1%, but the company still posted a $9.3 million net loss and a -21.4% operating margin.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management lifted 2026 revenue guidance to $180 million-$185 million and expects adjusted EBITDA of $15 million-$16 million, signaling continued top-line momentum.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →With the stock recently around $4.50 and fair value set at $5.50, the report sees upside, but not enough to justify a more aggressive rating.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report’s target framework places EVLV’s fair value at $5.50, supporting a Hold as growth improves but execution risk remains elevated.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Evolv has built a differentiated security platform with real operating traction. Q2 delivered 70 new customers, 34% revenue growth, 20% ARR growth, a 10.1% adjusted EBITDA margin, and continued eXpedite adoption. The company also has substantial room to expand from a base of about 9,200 units against more than 700,000 serviceable doorways.
The investment is still a development story rather than a finished compounder. Negative GAAP earnings, a forward EPS loss, mixed cash-flow records, material weaknesses in revenue recognition, supply-chain exposure, and a high-beta stock profile all deserve attention. A Hold stance near $4.50 reflects a business with meaningful upside if execution continues, but also enough unresolved risk to prevent a stronger rating for a moderate-risk investor.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Evolv Technologies Holdings, Inc. (EVLV) gained after a mixed Q2, with revenue in line but adjusted EPS missing estimates. This deep-dive looks beyond the headline at margin expansion, customer growth, recurring revenue mix, and the company’s long-term profitability framework.
Evolv Technologies is gaining traction with recurring revenue, expanding deployments, and improving margins, but the stock still faces profitability and credibility risks. Our view is a Hold as the valuation already reflects much of the growth story.
Evolv Technologies Holdings, Inc. (EVLV) gains 2.4% after reporting an earnings miss, as investors weigh the results against the stock's recent momentum.